NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-221-2004-0-PCT-02 Chondroitin Sulfate a Binding Domains PCT PCT PCT/US2005/035486 Expired
NCI E-327-2004-0-PCT-02 A New Approach Toward Macrocyclization Of Peptides PCT PCT PCT/US05/35246 Expired
NCI E-327-2004-0-EP-05 MACROCYCLIC SH2 DOMAIN BINDING INHIBITORS EP National Stage 05805719.1 Abandoned
NCI E-327-2004-0-AU-03 A New Approach Toward Macrocyclization Of Peptides AU National Stage 2005291957 Abandoned
NIA E-027-2005-0-US-01 METHODS AND COMPOSITIONS FOR MODULATING IMMUNE TOLERANCE US 60/722,675 Abandoned
NCI E-265-2005-0-US-01 Modification of Recombinant Ant-tumor RNase (rapLR1) For Optimal Use In The Large-scale Manufacture Of Stable And Potent RapLR1-antibody Conjugatyes US 60/722,295 Abandoned
NCI E-104-2007-0-US-01 Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence US 60/722,594 Abandoned
NCI E-218-2005-0-US-01 Method For Producing Protein Disulfide Conjugates US 60/722,898 Abandoned
NCI E-327-2004-0-CA-04 A New Approach Toward Macrocyclization Of Peptides CA National Stage 2582908 Abandoned
NCI E-044-2003-0-US-03 Enhanced HIV-1 Vaccine Methods for Their Use US National Stage 10/551,405 7731971 Abandoned PDF
NIAMS E-010-2005-0-US-01 Generation Of Regulatory T-cells For Immunotherapy US 60/722,505 Abandoned
NIAID E-023-2003-0-US-03 MVA Expressing Modified HIV Envelope, Gag, And Pol Genes US National Stage 11/238,155 7303754 Abandoned PDF
NCI E-104-2005-2-US-01 Alpha-defensins As Topical Inhibitor Of Human Papillovirus Infection US 60/722,027 Abandoned
NIAID E-319-2004-2-IL-07 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses IL National Stage 182225 Issued
NCI E-188-2004-0-EP-05 Nitric Oxide Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, And Compositions, Medical Devices, And Uses Thereof EP National Stage 05802080.1 Abandoned
NCI E-188-2004-0-GB-11 Nitric Oxide Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, And Compositions, Medical Devices, And Uses Thereof GB EP 05802080.1 Abandoned
NCI E-188-2004-0-FR-10 Nitric Oxide Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, And Compositions, Medical Devices, And Uses Thereof FR EP 05802080.1 Abandoned
NCI E-188-2004-0-DE-09 Nitric Oxide Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, And Compositions, Medical Devices, And Uses Thereof DE EP 05802080.1 Abandoned
NIAID E-319-2004-2-DE-18 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses DE EP 05813769.6 Issued
NIAID E-319-2004-2-FR-19 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses FR EP 05813769.6 Issued
NIAID E-319-2004-2-EP-05 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses EP National Stage 05813769.6 Issued
NIAID E-319-2004-2-IT-21 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses IT EP 05813769.6 Issued
NIAID E-319-2004-2-CH-17 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses CH EP 05813769.6 Issued
NIAID E-319-2004-2-GB-20 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses GB EP 05813769.6 Issued
NIAID E-319-2004-2-NL-22 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses NL EP 05813769.6 Issued
NIAID E-319-2004-2-BE-16 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses BE EP 05813769.6 Issued
NIAID E-319-2004-2-CA-04 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses CA National Stage 2581840 Issued
NIAID E-319-2004-2-IN-08 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses IN National Stage 2674/DELNP/2007 Issued
NCI E-188-2004-0-CA-04 Nitric Oxide Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, And Compositions, Medical Devices, And Uses Thereof CA National Stage 2581939 Abandoned
NIAID E-319-2004-2-JP-09 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses JP National Stage 2007-533758 Issued
NIAID E-319-2004-2-AU-03 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses AU National Stage 2005289439 Issued
NCI E-188-2004-0-AU-03 Nitric Oxide Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, And Compositions, Medical Devices, And Uses Thereof AU National Stage 2005289414 Abandoned
NICHD E-107-2003-0-US-04 A New Vaccine For Lyme Disease (Borrelia Burgdorferi) US National Stage 10/550,907 7666846 Abandoned PDF
NIAID E-319-2004-2-SG-10 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses1 SG National Stage 200702299-9 Issued
NIAID E-319-2004-2-ZA-12 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses ZA National Stage 2007/03260 Issued
NCI E-257-2004-0-PCT-02 Modulating MxA Expression PCT PCT PCT/US2005/034849 Expired
NIAID E-319-2004-2-PCT-01 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses PCT PCT COMB PCT/US2005/034798 Expired
NCI E-188-2004-0-PCT-02 Nitric Oxide Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, And Compositions, Medical Devices, And Uses Thereof PCT PCT PCT/US2005/35065 Expired
NCI E-257-2004-0-EP-05 Modulating MxA Expression EP National Stage 05811928.0 Abandoned
NCI E-257-2004-0-AU-03 Modulating MxA Expression AU National Stage 2005289453 Abandoned
NCI E-257-2004-0-CA-04 Modulating MxA Expression CA National Stage 2581930 Abandoned
NCI E-219-1992-0-JP-11 PEPTIDE INHIBITORS OF FIBRONECTIN AND RELATED COLLAGEN BINDING- PROTEINS JP DIV 2005-282907 Abandoned
NIDDK E-324-2004-2-US-01 In Vitro Model For Hepatitis C Virion Production US 60/720,692 Abandoned
NINDS E-084-2003-2-US-02 Identification, Quantification, And Characterization Of T Cells And T Cell Antigens US National Stage 10/551,126 Abandoned
NINDS E-041-2003-0-US-03 HeadWave Clinical Coil Design For Magnetic Resonance Elastography US National Stage 10/550,757 Abandoned
NCI E-287-2004-1-PCT-01 IRTA2 ANTIBODIES AND METHODS OF USE PCT PCT COMB PCT/US2005/034444 Expired
NIAID E-241-2004-0-ES-06 Method of Detecting Cancer Based On Immune Reaction To BORIS ES EP 05799643.1 Issued
NIAID E-241-2004-0-FR-07 Method of Detecting Cancer Based On Immune Reaction To BORIS FR EP 05799643.1 Issued
NIAID E-241-2004-0-DE-05 Method of Detecting Cancer Based On Immune Reaction To BORIS DE EP 05799643.1 Issued
NIAID E-241-2004-0-EP-03 Method of Detecting Cancer Based On Immune Reaction To BORIS EP National Stage 05799643.1 Issued